Marianna Bruno

发表

Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges

Adam Castaño, J. Grodin, Marianna Bruno, 2020, Heart Failure Reviews.

Smoking Cessation Is Associated With Lower Indirect Costs

A. Goren, B. Emir, C. Baker, 2018, Journal of occupational and environmental medicine.

Applying diagnosis support systems in electronic health records to identify wild-type transthyretin amyloid cardiomyopathy risk.

Kensaku Kawamoto, K. Nolen, T. Kannampallil, 2022, Future cardiology.

BE EMPOWERED, A Specialty Pharmacy Education Program for Hemophilia B Patients, Impacts Adult Joint Bleeds and Pediatric Use of RICE

B. Tortella, Marianna Bruno, C. S. Blankenship, 2014, Journal of managed care pharmacy : JMCP.

Characterization of the first adult de novo case of 46,X,der(Y)t(X;Y)(p22.3;q11.2).

M. R. Lipsi, R. Antonetti, L. Valente, 2013, Gene.

Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story

D. Judge, J. Kelly, J. Patel, 2021, Drug design, development and therapy.

Estimated Budget Impact of Adopting the Affordable Care Act’s Required Smoking Cessation Coverage on United States Healthcare Payers

C. Ferrufino, C. Baker, S. Kowal, 2016, Advances in Therapy.

Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United States

L. Gilstrap, J. Kemner, R. Bhambri, 2023, American Journal of Cardiovascular Drugs.

A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy

Rahul C. Deo, Sanjiv J. Shah, R. Deo, 2021, Nature Communications.

SCREENING OF PATIENTS AT RISK FOR WILD TYPE ATTR-CM USING A COMPUTATIONAL MACHINE LEARNING ALGORITHM

Kensaku Kawamoto, J. Biskupiak, J. Nativi-Nicolau, 2021, Journal of the American College of Cardiology.

A Pragmatic Randomized Trial Comparing Telephone-Based Enhanced Pharmacy Care and Usual Care to Support Smoking Cessation

K. Zou, D. Lawrence, J. Gong, 2016, Journal of managed care & specialty pharmacy.

Content Validity of a Willingness to Quit Tool for Use with Current Smokers in Clinical Practice

E. Brohan, B. Bennett, B. Emir, 2017, Advances in Therapy.

Healthcare Costs of Smokers Using Varenicline Versus Nicotine-Replacement Therapy Patch in the United States: Evidence from Real-World Practice

M. Reynolds, B. Emir, Surbhi Shah, 2018, Advances in Therapy.

Benefits of quitting smoking on work productivity and activity impairment in the United States, the European Union and China

K. Zou, N. Flores, C. Baker, 2017, International journal of clinical practice.

Clinical characteristics and health care resource use of patients at risk for wild-type transthyretin amyloid cardiomyopathy identified by machine learning model

E. Casey, R. Sheer, Radhika Nair, 2023, Journal of managed care & specialty pharmacy.

Implementing a Machine-Learning-Adapted Algorithm to Identify Possible Transthyretin Amyloid Cardiomyopathy at an Academic Medical Center

T. Kannampallil, D. Lenihan, Joshua D. Mitchell, 2022, Clinical Medicine Insights. Cardiology.

Mobile App Usage Patterns of Patients Prescribed a Smoking Cessation Medicine: Prospective Observational Study

B. Emir, C. Baker, C. Sigler, 2018, JMIR mHealth and uHealth.

Transthyretin Amyloid Cardiomyopathy Among Patients Hospitalized for Heart Failure and Performance of an Adapted Wild-Type ATTR-CM Machine Learning Model: Findings from GWTG-HF.

Michel G Khouri, G. Fonarow, L. Allen, 2023, American heart journal.

Performance Evaluation of A Machine Learning Model For Systematic Identification of Wild-type Transthyretin Amyloid Cardiomyopathy At Two Academic Medical Centers

Miriam R. Elman, A. Masri, S. Heitner, 2020 .

Clinical characteristics and health care resource use of patients at risk for wild-type transthyretin amyloid cardiomyopathy identified by machine learning model

E. Casey, R. Sheer, Radhika Nair, 2023, Journal of Managed Care & Specialty Pharmacy.

EstimATTR: A Simplified, Machine-Learning-Based Tool to Predict the Risk of Wild-Type Transthyretin Amyloid Cardiomyopathy.

Ahsan Huda, Marianna Bruno, Sanjiv J. Shah, 2023, Journal of cardiac failure.